2050 Capital

About The Fund

2050 Capital is an early-stage venture capital firm that specializes in deep tech and science investments, focusing on transformative and defensible innovation that impacts large fundamental sectors. The firm exhibits a strong preference for enterprise software with a deep science component, computational biotech, and various engineering and science ventures. 2050 Capital is not keen on investing in businesses that lack a deep tech or science angle such as marketplaces, apps, or marketing-led ventures. Additionally, they avoid ventures that require extended R&D timelines of more than 7 years to exit. The firm deploys approximately 1 million from principals and syndicates into 2 to 3 deals annually, with ticket sizes ranging from $200,000 to $1 million. They position themselves as disciplined and surgical investors, conducting thorough due diligence and co-investing with experts in every deal. Their investment approach is backed by the belief that significant positive change requires substantial time and effort without shortcuts, both from the founders and from the investors. Upon investing, 2050 Capital becomes active partners with their portfolio companies, assisting with business development, strategy, and next-stage fundraising. They typically write $200,000 to $500,000 seed checks and invest up to $3 million in subsequent rounds. The firm has a strong record of follow-on investments, with over 50% of their investments made in follow-ons. As a part of their portfolio support, they state that once they become investors, they align themselves as partners who are committed to the founders' visionary goals. 2050 Capital underlines a success story with a portfolio that spans thirteen companies across twenty-two transactions, with a 70% appreciation rate. Their portfolio includes companies like AMFG, Blackrock Neurotech, ChAI, Hadean, KETS, Origin Sciences, Snyk, and OSCP. The firm indicates on their website that interested companies should get in touch if they meet their investment criteria, emphasizing their openness to new opportunities that align with their investment thesis.